Policy & Medicine - Legal, Regulatory, and Compliance Issues

“Economic activity that is fueled by research and innovation in the biological sciences, the “bioeconomy,” is a large…

The Food and Drug Administration (FDA) recently published an Issue Paper discussing the use of surveys to assess whether a risk…

Lilly Diabetes and Walgreens are educating people living with diabetes about one of the most common and misunderstood consequences…

“Medicines Australia (MA) is an industry association whose members represent multinational, research-based pharmaceutical…

A recent article from Reuters Health looked at the difficult challenges that clinical trials of cancer treatment face.  One of the…

This year, it is estimated that 365,000 women will die from complications of pregnancy and childbirth.  A great many of these…

Deaths from painkiller overdoses have tripled over the last decade and led to the deaths of 14,800 Americans in 2008, exceeding…

Continuing the ongoing trend of transparency and disclosure in the health care industry, Forest Laboratories became the latest in…

Last week, the National Institutes of Health unveiled a collaborative program that will match researchers with a selection of…

The Centers for Medicare & Medicaid Services recently announced a final rule that prevents fraud in Medicare and is estimated…